Needham & Company LLC Reaffirms “Buy” Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research note issued on Monday,Benzinga reports. They currently have a $320.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 34.47% from […]
More Stories
SEO for Manufacturing Companies: Strategies to Generate High-Quality Leads
SEO has become the biggest part of life in this competitive world. The efficient use of SEO can be done...
The USA “Needs Greenland for the Purpose of National Security”: Trump Remains Adamant
On 14 January, US President Donald Trump declared that “anything less than having Greenland in the hands of the United...
Trump Threatens to Invoke Insurrection Act to End Anti-ICE Protests in Minnesota
By Sam Dorman President Donald Trump has threatened to use the Insurrection Act in Minnesota following an attack on an...
How ICE Was Targeted in Minneapolis for Weeks Before Fatal Shooting
By Jacki Thrapp MINNEAPOLIS—Activists in Minneapolis are continuing to organize efforts to impede immigration enforcement as the Trump administration surges...
Trump Says US Control of Greenland Would Make NATO Stronger
By Tom Ozimek President Donald Trump said on Jan. 14 that NATO would be a stronger and more credible deterrent...
Constraining Mega-Landlords Would Help Some Buyers, Won’t Solve Housing Woes: Industry Insiders
By Petr Svab President Donald Trump’s proposed ban on large corporate landlords buying more single-family homes could help families looking...